Compounds > lysine
Page last updated: 2024-08-17

lysine and HIV Coinfection

lysine has been researched along with HIV Coinfection in 33 studies

Research

Studies (33)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (12.12)18.2507
2000's8 (24.24)29.6817
2010's17 (51.52)24.3611
2020's4 (12.12)2.80

Authors

AuthorsStudies
Balasubramaniam, M; Burge, N; Christensen, D; Cox, K; Craigie, R; Dash, C; Kvaratskhelia, M; Li, M; Linderberger, J; Pandhare, J; Poirier, MG; Prakash, P; Sapp, N; Thapa, S1
Huang, H; Jiang, QA; Jin, X; Ma, L; Sun, L; Wang, JH; Yang, X; Zhang, C1
Bart, SM; Bates, P; Bitan, G; Bravo-Rodriguez, K; Dwivedi, M; Ehrmann, M; Erwin, N; Groß, R; Harms, M; Hebel, M; Heid, C; Klärner, FG; Kreppel, F; Le, MH; Lippold, S; Müller, JA; Münch, J; Read, C; Röcker, A; Ruiz-Blanco, YB; Sanchez-Garcia, E; Schrader, T; Shorter, J; Sowislok, A; Sparrer, K; Stürzel, CM; von Einem, J; Walther, P; Weil, T; Wettstein, L; Winter, R1
Bossis, G; Buchrieser, J; Casartelli, N; Coggins, SA; Cormier, A; Diaz-Griffero, F; Espert, L; Kim, B; Lesage, P; Mahboubi, B; Margottin-Goguet, F; Martinat, C; Palmic, N; Persaud, M; Saïb, A; Schwartz, O; Tobaly-Tapiero, J; Zamborlini, A1
Atis, M; Elber, R; Johnson, KA1
Butorov, EV3
Biswas, S; Devadas, K; Haleyurgirisetty, M; Hewlett, I; Lee, S; Ragupathy, V; Wang, X1
DiMaio, D; Luo, Y; Marlatt, SA; Petti, LM; Scheideman, EH; Shelar, A1
Bekker, V; Bhiman, JN; Dirr, H; Fernandes, MA; Ferrari, G; Garrett, N; Haynes, BF; Hermanus, T; Ismail, A; Karim, SA; Lambson, B; Mabvakure, B; Mkhize, NN; Moody, MA; Moore, PL; Morris, L; Nonyane, M; Richardson, SI; Sayed, Y; Scheepers, C; Shapiro, L; Sheng, Z; Stanfield-Oakley, S; van Eeden, C; Vijayakumar, B; Wibmer, CK; Wiehe, K1
Meslamani, J; Sanchez, R; Zhou, MM1
Ai, Y; Ma, J1
Ernst, J; Ettyang, G; Neumann, CG1
Adzhubei, AA; Anashkina, AA; Brichacek, B; Bukrinsky, M; Dubrovsky, L; Hunegnaw, R; Pushkarsky, T; Sviridov, D; Üren, A; Vassylyev, DG; Vassylyeva, M1
Aubertin, AM; Boustta, M; Couffin-Hoarau, AC; Fehrentz, JA; Martinez, J; Schmidt, S; Vert, M1
Chan, DS; Gronenborn, AM; Iwatani, Y; Levin, JG; Liu, L; Shibata, J; Sugiura, W; Yamamoto, N; Yoshii, H1
An, X; Guo, X; He, L; Jiang, S; Li, L; Liu, S; Lu, H; Pan, C; Qi, Z; Tan, S1
Daelemans, D; Pardon, E; Steyaert, J; Vanstreels, E; Vercruysse, T1
Burlein, C; Carroll, SS; DiStefano, DJ; Gregro, AR; Grobler, JA; Lai, MT; Mitra, AW; Moore, KP; Nantermet, PG; Paton, BL; Rajapakse, HA; Sanchez, RI; Tinney, E; Touch, S; Vacca, JP; Walji, AM; Williams, TM; Zhu, H1
Archin, NM; Cho, WK; Chu, CK; Friedman, J; Karn, J; Keedy, KS; Margolis, DM1
Amutha, R; Mathur, PP; Muthukumaran, R; Sangeetha, B1
McCulley, A; Ratner, L1
Artuch, R; Fortuny, C; López-Vilches, MA; Muñoz-Almagro, C; Pineda, J; Sierra, C; Vilaseca, MA1
Akinsete, O; Cartwright, C; Henry, K; Hirigoyen, D; Kantor, R; Schut, R1
Bevec, D; Choidas, A; Harrer, T; Hauber, I; Hauber, J; Heukeshoven, J; Horn, F; Krätzer, F1
Chen, B; Derrick, SC; Jacobs, WR; Jalapathy, KV; Morris, SL; Russell, RG; Sambandamurthy, VK1
Alfano, M; Contini, P; Poggi, A; Zocchi, MR1
Dwyer, E; Itescu, S; Rose, S; Winchester, R1
Baumruker, T; Bevec, D; Hauber, J; Holter, W; Klier, H; Lottspeich, F; Tschachler, E; Valent, P1
Inuzuka, S; Mizokami, M; Morozumi, H; Nagata, M; Nakano, T; Okamoto, T; Taguchi, Y1
Allen, RL; Brander, C; Conlon, C; Dyer, W; Goulder, P; Holmes, EC; Jones, I; Kelleher, AD; Long, C; McMichael, AJ; Ogg, G; Olson, K; Phillips, RE; Rowland-Jones, S; Shaunak, S; Sullivan, JS; Wilson, J; Workman, C1
de Clercq, E; Jansen, RW; Meijer, DK; Molema, G; Pauwels, R1

Reviews

1 review(s) available for lysine and HIV Coinfection

ArticleYear
The bromodomain: from epigenome reader to druggable target.
    Biochimica et biophysica acta, 2014, Volume: 1839, Issue:8

    Topics: Acetylation; Cardiovascular Diseases; Epigenesis, Genetic; Histones; HIV Infections; Humans; Lysine; Models, Molecular; Neoplasms; Protein Conformation; Protein Interaction Domains and Motifs; Protein Processing, Post-Translational; Protein Structure, Tertiary; Small Molecule Libraries; Transcription Factors

2014

Trials

1 trial(s) available for lysine and HIV Coinfection

ArticleYear
High-nutrition biscuits to increase animal protein in diets of HIV-infected Kenyan women and their children: a study in progress.
    Food and nutrition bulletin, 2014, Volume: 35, Issue:4 Suppl

    Topics: Animals; Child; Child, Preschool; Diet; Dietary Proteins; Dietary Supplements; Female; Glycine max; Health Status; HIV Infections; Humans; Infant; Iron; Kenya; Lysine; Meat; Nutritional Status; Nutritive Value; Rural Population; Triticum; Vitamin B 12; Zinc

2014

Other Studies

31 other study(ies) available for lysine and HIV Coinfection

ArticleYear
HIV-1 Preintegration Complex Preferentially Integrates the Viral DNA into Nucleosomes Containing Trimethylated Histone 3-Lysine 36 Modification and Flanking Linker DNA.
    Journal of virology, 2022, 09-28, Volume: 96, Issue:18

    Topics: Chromatin; Chromosomes, Human; DNA, Viral; Histone Code; Histones; HIV Infections; HIV Integrase; HIV-1; Humans; Lysine; Methylation; Nucleosomes; Virus Integration

2022
X-Linked RNA-Binding Motif Protein Modulates HIV-1 Infection of CD4
    mBio, 2020, 04-21, Volume: 11, Issue:2

    Topics: CD4-Positive T-Lymphocytes; Gene Expression Regulation, Viral; Gene Knockdown Techniques; Heterogeneous-Nuclear Ribonucleoproteins; Histones; HIV Infections; HIV Long Terminal Repeat; HIV-1; Humans; Lysine; Methylation; Protein Binding; Proviruses; Transcription, Genetic

2020
Supramolecular Mechanism of Viral Envelope Disruption by Molecular Tweezers.
    Journal of the American Chemical Society, 2020, 10-07, Volume: 142, Issue:40

    Topics: Acid Phosphatase; Amyloid; Anti-HIV Agents; Antiviral Agents; Arginine; Betacoronavirus; Bridged-Ring Compounds; Cell Membrane; HIV Infections; HIV-1; Humans; Lipids; Lysine; Magnetic Resonance Spectroscopy; Organophosphates; SARS-CoV-2; Seminal Vesicle Secretory Proteins; Structure-Activity Relationship; Viral Envelope Proteins; Zika Virus

2020
SUMOylation of SAMHD1 at Lysine 595 is required for HIV-1 restriction in non-cycling cells.
    Nature communications, 2021, 07-28, Volume: 12, Issue:1

    Topics: Amino Acid Substitution; Cell Cycle; HEK293 Cells; HIV Infections; HIV-1; Humans; Lysine; Mutation; Phosphorylation; SAM Domain and HD Domain-Containing Protein 1; Sumoylation; U937 Cells

2021
Pyrophosphate Release in the Protein HIV Reverse Transcriptase.
    The journal of physical chemistry. B, 2017, 10-19, Volume: 121, Issue:41

    Topics: Diphosphates; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lysine; Magnesium; Molecular Dynamics Simulation; Substrate Specificity; Thermodynamics

2017
Impact of High Protein Intake on Viral Load and Hematological Parameters in HIV-infected Patients.
    Current HIV research, 2017, Nov-23, Volume: 15, Issue:5

    Topics: Adult; Case-Control Studies; Feeding Behavior; HIV Infections; Humans; Lysine; Male; Middle Aged; Proteins; RNA, Viral; Siberia; Surveys and Questionnaires; Viral Load

2017
Differentially expressed host long intergenic noncoding RNA and mRNA in HIV-1 and HIV-2 infection.
    Scientific reports, 2018, 02-07, Volume: 8, Issue:1

    Topics: Cullin Proteins; Gene Expression Profiling; Glutathione; HIV Infections; HIV-1; HIV-2; Humans; Lysine; Macrophages; Retinoblastoma-Binding Protein 4; RNA, Long Noncoding; RNA, Messenger; Serine-Arginine Splicing Factors

2018
Regulation of C-C chemokine receptor 5 (CCR5) stability by Lys
    The Journal of biological chemistry, 2018, 06-08, Volume: 293, Issue:23

    Topics: Animals; Aptamers, Peptide; Cell Line; HIV; HIV Infections; Humans; Lysine; Lysosomes; Mice; Proteolysis; Receptors, CCR5

2018
V2-Directed Vaccine-like Antibodies from HIV-1 Infection Identify an Additional K169-Binding Light Chain Motif with Broad ADCC Activity.
    Cell reports, 2018, 12-11, Volume: 25, Issue:11

    Topics: AIDS Vaccines; Alleles; Amino Acid Sequence; Antibody-Dependent Cell Cytotoxicity; HIV Antibodies; HIV Envelope Protein gp120; HIV Infections; Humans; Immunoglobulin Light Chains; Lysine; Models, Molecular; Peptides; Protein Binding; Tissue Donors

2018
Relationship between plasma l-lysine concentrations and levels of HIV-1 RNA.
    Virulence, 2013, Oct-01, Volume: 4, Issue:7

    Topics: Adult; Female; HIV Infections; HIV-1; Humans; Lysine; Male; Plasma; RNA, Viral; Viral Load; Young Adult

2013
Multiple lysines combined in HIV-1 Vif determines the responsiveness to CBF-β.
    Biochemical and biophysical research communications, 2015, Feb-13, Volume: 457, Issue:3

    Topics: Amino Acid Substitution; Core Binding Factor beta Subunit; HEK293 Cells; HIV Infections; HIV-1; Host-Pathogen Interactions; Humans; Lysine; Mutagenesis, Site-Directed; Proteasome Endopeptidase Complex; Proteolysis; Recombinant Proteins; vif Gene Products, Human Immunodeficiency Virus; Virulence

2015
Influence of L-lysine amino acid on the HIV-1 RNA replication in vitro.
    Antiviral chemistry & chemotherapy, 2015, Volume: 24, Issue:1

    Topics: Adult; Amino Acid Oxidoreductases; Arginine; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Lysine; Male; Pilot Projects; RNA, Viral; Virus Replication; Young Adult

2015
Interaction Between HIV-1 Nef and Calnexin: From Modeling to Small Molecule Inhibitors Reversing HIV-Induced Lipid Accumulation.
    Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:9

    Topics: Anthraquinones; Atherosclerosis; ATP Binding Cassette Transporter 1; Biological Transport; Calnexin; Cholesterol; Computer-Aided Design; Drug Design; Foam Cells; HEK293 Cells; HIV Infections; Humans; Hypolipidemic Agents; Lysine; Molecular Docking Simulation; Mutation; nef Gene Products, Human Immunodeficiency Virus; Protein Binding; Protein Interaction Domains and Motifs; Structure-Activity Relationship; Transfection

2016
Peptide-poly(L-lysine citramide) conjugates and their in vitro anti-HIV behavior.
    Biomacromolecules, 2009, Apr-13, Volume: 10, Issue:4

    Topics: Animals; Anti-HIV Agents; Body Weight; Cell Line; Chromatography, Thin Layer; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Inhibitory Concentration 50; Lymphocytes; Lysine; Magnetic Resonance Spectroscopy; Mice; Peptide Fragments; Polylysine; Polymers; Spectroscopy, Fourier Transform Infrared

2009
HIV-1 Vif-mediated ubiquitination/degradation of APOBEC3G involves four critical lysine residues in its C-terminal domain.
    Proceedings of the National Academy of Sciences of the United States of America, 2009, Nov-17, Volume: 106, Issue:46

    Topics: APOBEC-3G Deaminase; Cell Line; Cytidine Deaminase; HIV Infections; HIV-1; Humans; Lysine; Protein Binding; Protein Structure, Tertiary; Ubiquitination; vif Gene Products, Human Immunodeficiency Virus

2009
3-hydroxyphthalic anhydride-modified chicken ovalbumin exhibits potent and broad anti-HIV-1 activity: a potential microbicide for preventing sexual transmission of HIV-1.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Animals; Anti-HIV Agents; Arginine; Chickens; CHO Cells; Cricetinae; Cricetulus; Drug Design; Epithelial Cells; Female; HIV Envelope Protein gp41; HIV Infections; HIV-1; HIV-2; Humans; Interferon-gamma; Leukocytes, Mononuclear; Lysine; Membrane Fusion; Molecular Weight; Ovalbumin; Phthalic Anhydrides; Protein Structure, Secondary; Sexually Transmitted Diseases, Viral; Simian Immunodeficiency Virus

2010
An intrabody based on a llama single-domain antibody targeting the N-terminal alpha-helical multimerization domain of HIV-1 rev prevents viral production.
    The Journal of biological chemistry, 2010, Jul-09, Volume: 285, Issue:28

    Topics: Active Transport, Cell Nucleus; Amino Acid Sequence; Animals; Anti-HIV Agents; Antibodies; Camelids, New World; Dimerization; Fluorescence Resonance Energy Transfer; Gene Products, rev; HeLa Cells; HIV Infections; HIV-1; Humans; Lysine; Molecular Sequence Data; Protein Interaction Mapping; Protein Structure, Secondary; Protein Structure, Tertiary; Tyrosine

2010
Strategies towards improving the pharmacokinetic profile of ε-substituted lysinol-derived HIV protease inhibitors.
    ChemMedChem, 2011, Feb-07, Volume: 6, Issue:2

    Topics: Antiretroviral Therapy, Highly Active; HIV Infections; HIV Protease Inhibitors; Lysine; Structure-Activity Relationship

2011
Epigenetic silencing of HIV-1 by the histone H3 lysine 27 methyltransferase enhancer of Zeste 2.
    Journal of virology, 2011, Volume: 85, Issue:17

    Topics: Chromatin Immunoprecipitation; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Gene Knockdown Techniques; Histone-Lysine N-Methyltransferase; Histones; HIV Infections; HIV-1; Humans; Jurkat Cells; Lysine; Polycomb Repressive Complex 2; Transcription Factors; Virus Latency

2011
Development of anti-HIV activity models of lysine sulfonamide analogs: a QSAR perspective.
    Current computer-aided drug design, 2012, Volume: 8, Issue:1

    Topics: HIV; HIV Infections; HIV Protease; HIV Protease Inhibitors; Humans; Lysine; Models, Statistical; Molecular Dynamics Simulation; Protein Binding; Quantitative Structure-Activity Relationship; Sulfonamides; Thermodynamics

2012
HIV-2 viral protein X (Vpx) ubiquitination is dispensable for ubiquitin ligase interaction and effects on macrophage infection.
    Virology, 2012, May-25, Volume: 427, Issue:1

    Topics: Amino Acid Sequence; Amino Acid Substitution; Carrier Proteins; HEK293 Cells; HeLa Cells; HIV Infections; HIV-2; Humans; Lysine; Macrophages; Molecular Sequence Data; Protein Serine-Threonine Kinases; Ubiquitin-Protein Ligase Complexes; Ubiquitin-Protein Ligases; Ubiquitination; Viral Regulatory and Accessory Proteins; Virion; Virus Replication

2012
Low serum carnitine in HIV-infected children on antiretroviral treatment.
    European journal of clinical nutrition, 2003, Volume: 57, Issue:10

    Topics: Adolescent; Anti-Retroviral Agents; Carnitine; Child; Child, Preschool; Cross-Sectional Studies; Female; HIV Infections; Humans; Infant; Lysine; Male; Methionine; Prospective Studies; Protease Inhibitors

2003
K103N mutation in antiretroviral therapy-naive African patients infected with HIV type 1.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Aug-15, Volume: 39, Issue:4

    Topics: Amino Acid Substitution; Antiretroviral Therapy, Highly Active; Asparagine; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Lysine; Male; Middle Aged; Mutation, Missense; RNA-Directed DNA Polymerase; Viral Proteins

2004
Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy.
    The Journal of clinical investigation, 2005, Volume: 115, Issue:1

    Topics: Anti-HIV Agents; Cells, Cultured; Drug Resistance, Multiple; Gene Expression Regulation, Viral; Gene Products, rev; HIV Infections; HIV-1; Humans; Hydrazones; Kinetics; Lysine; Macrophages; Oxidoreductases Acting on CH-NH Group Donors; Phenotype; rev Gene Products, Human Immunodeficiency Virus; RNA Interference; T-Lymphocytes; Transcriptional Activation; Virus Replication

2005
Long-term protection against tuberculosis following vaccination with a severely attenuated double lysine and pantothenate auxotroph of Mycobacterium tuberculosis.
    Infection and immunity, 2005, Volume: 73, Issue:2

    Topics: Animals; HIV Infections; Humans; Lysine; Mice; Mycobacterium tuberculosis; Pantothenic Acid; Time Factors; Tuberculosis; Tuberculosis Vaccines; Vaccines, Attenuated

2005
Pertussis toxin (PTX) B subunit and the nontoxic PTX mutant PT9K/129G inhibit Tat-induced TGF-beta production by NK cells and TGF-beta-mediated NK cell apoptosis.
    Journal of immunology (Baltimore, Md. : 1950), 2005, May-15, Volume: 174, Issue:10

    Topics: Adjuvants, Immunologic; Amino Acid Substitution; Apoptosis; bcl-X Protein; Cells, Cultured; Down-Regulation; Enzyme Activation; Gene Products, tat; Glycine; HIV Infections; HIV-1; Humans; Killer Cells, Natural; Lysine; Pertussis Toxin; Phosphorylation; Protein Serine-Threonine Kinases; Protein Subunits; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; tat Gene Products, Human Immunodeficiency Virus; Transcription Factor AP-1; Transcription, Genetic; Transforming Growth Factor beta; Vaccines, Subunit

2005
Grouping HLA-B locus serologic specificities according to shared structural motifs suggests that different peptide-anchoring pockets may have contrasting influences on the course of HIV-1 infection.
    Human immunology, 1995, Volume: 42, Issue:1

    Topics: Adult; AIDS-Related Opportunistic Infections; Antigen Presentation; Binding Sites; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Child; Disease Progression; Disease Susceptibility; Gene Frequency; Genetic Predisposition to Disease; HIV Infections; HIV-1; HLA-B Antigens; HLA-B35 Antigen; Humans; Lymphocyte Count; Lysine; Peptide Fragments; Protein Binding; Protein Conformation

1995
Induced gene expression of the hypusine-containing protein eukaryotic initiation factor 5A in activated human T lymphocytes.
    Proceedings of the National Academy of Sciences of the United States of America, 1994, Nov-08, Volume: 91, Issue:23

    Topics: Base Sequence; Cell Division; Cell Line; Cells, Cultured; DNA Primers; Electrophoresis, Gel, Two-Dimensional; Eukaryotic Translation Initiation Factor 5A; Gene Expression; HIV Infections; Humans; In Vitro Techniques; Lymphocyte Activation; Lysine; Molecular Sequence Data; Peptide Chain Initiation, Translational; Peptide Initiation Factors; RNA-Binding Proteins; RNA, Messenger; T-Lymphocytes; Time Factors

1994
Clonal selection of HIV type 1 variants associated with resistance to foscarnet in vitro: confirmation by molecular evolutionary analysis.
    AIDS research and human retroviruses, 1997, May-01, Volume: 13, Issue:7

    Topics: Amino Acid Sequence; Anti-HIV Agents; Arginine; Biological Evolution; Cells, Cultured; Cloning, Molecular; DNA, Viral; Drug Resistance, Microbial; Foscarnet; Gene Expression Regulation, Viral; Genes, pol; Genetic Variation; HIV Infections; HIV-1; Humans; Lysine; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid; T-Lymphocytes; Virus Replication

1997
Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.
    The Journal of experimental medicine, 2001, Feb-05, Volume: 193, Issue:3

    Topics: Arginine; Base Sequence; Codon; DNA, Viral; Glycine; HIV Core Protein p24; HIV Infections; HIV Long-Term Survivors; HIV-1; HLA-B27 Antigen; Humans; Lysine; Male; Molecular Sequence Data; Mutagenesis, Site-Directed; Phylogeny; T-Lymphocytes, Cytotoxic

2001
Targeting of antiviral drugs to T4-lymphocytes. Anti-HIV activity of neoglycoprotein-AZTMP conjugates in vitro.
    Biochemical pharmacology, 1990, Dec-15, Volume: 40, Issue:12

    Topics: Antiviral Agents; CD4-Positive T-Lymphocytes; Dideoxynucleotides; Drug Carriers; Glycoproteins; HIV Infections; Humans; In Vitro Techniques; Lysine; Serum Albumin; Thymine Nucleotides; Zidovudine

1990